Suchergebnisse - "Uchino, Junji"

PubPharm (175)

71

Rationale and design of a phase II trial of osimertinib as first-line treatment for elderly patients with epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer (SPIRAL-0 study)

enthalten in: Translational lung cancer research | 2019

von Chihara, Y. | Yamada, T. | Uchino, J. | +4

72

Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer

enthalten in: Journal of cancer research and clinical oncology | 2019

von Imai, H. | Wasamoto, S. | Yamaguchi, O. | +15

73

Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer

enthalten in: Journal of cancer research and clinical oncology | 2019

von Imai, H. | Wasamoto, S. | Yamaguchi, O. | +15

74

Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer

enthalten in: Journal of cancer research and clinical oncology | 2019

von Imai, H. | Wasamoto, S. | Yamaguchi, O. | +15

75

Phase I/II Study of Docetaxel and S-1 in Previously-Treated Patients with Advanced Non-Small Cell Lung Cancer : LOGIK0408

enthalten in: Journal of clinical medicine | 2019

von Takayama, K. | Uchino, J. | Fujita, M. | +9

76

Erlotinib as standard adjuvant therapy for resectable EGFR mutation-positive non-small cell lung cancer

enthalten in: Translational lung cancer research | 2019

von Tanaka, S. | Uchino, J.

CommentOn: Lancet Respir Med. 2018 Nov;6(11):863-873. - PMID 30150014

77

Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer

enthalten in: The oncologist | 2019

von Takayama, K. | Ichiki, M. | Tokunaga, S. | +4

78

Comparing three different anti-PD-L1 antibodies for immunohistochemical evaluation of small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2019

von Yoshimura, A. | Yamada, T. | Miyagawa-Hayashino, A. | +12

79

Phase II Study of S-1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non-Small Cell Lung Cancer

enthalten in: The oncologist | 2019

von Chihara, Y. | Yoshimura, A. | Date, K. | +12

80

Clinical features of immune-related thyroid dysfunction and its association with outcomes in patients with advanced malignancies treated by PD-1 blockade

enthalten in: Oncology letters | 2019

von Sakakida, T. | Ishikawa, T. | Uchino, J. | +16